PharmaCyte Biotech Successfully Monetizes Femasys Stake, Strengthening Cash Position and Underscoring Strategic Capital Deployment
LAS VEGAS–(BUSINESS WIRE)–PharmaCyte Biotech, Inc. (Nasdaq:PMCB) (“PharmaCyte” or the “Company”), today announced the successful monetization... Read more.
Tom Brady, Druski, and Gopuff Team Up with The Super Monday Off Coalition to Make the Monday After the Big Game a National Holiday
Gopuff launches HARD PASS campaign to support a 501(c)(4) nonprofit dedicated to lobbying Congress to make the Monday after the Big Game a federal holiday PHILADELPHIA–(BUSINESS... Read more.
UST Appointed Exclusive Digital Technology Partner by Aviva Investors
LONDON–(BUSINESS WIRE)–#AI—UST, a leading AI and technology transformation solutions company, has been selected by Aviva Investors, the global... Read more.
Wolters Kluwer announces TaxWise® Online powered by Expert AI: Introducing AI-driven features for tax preparers
Empowering tax preparers with unified AI innovations for faster, smarter, and more connected tax preparation MINNEAPOLIS–(BUSINESS WIRE)–Wolters Kluwer... Read more.
NMI Research: 63% of Millennial Parents Say Holiday Shopping Budgets are Tighter This Year, and Yet Three-Quarters are Willing to Pay More for Convenience
Over a quarter of Millennial parents (27%) will spend over $500 per child, yet over half (51%) say long lines in-store cause them to walk away without completing... Read more.
Frost Bank Implements Derivative Path to Power OTC Derivatives Business
NEW YORK–(BUSINESS WIRE)–Derivative Path, a leading provider of cloud-based derivatives trading and risk management technology, today announced that... Read more.
Most Popular Best’s Review Articles Include ‘New Technology Helps Prevent Workplace Injuries’ and More
OLDWICK, N.J.–(BUSINESS WIRE)–#insurance–In the past 30 days, Best’s Review readers have been most interested in the following insurance news... Read more.
Inflammasome Therapeutics Completes Enrollment of Multicenter Phase II Dose- Ranging Study for First-in-Class Dual Inflammasome Inhibitor, K8, to Treat Geographic Atrophy
NEWTON, Mass.–(BUSINESS WIRE)–#NRTIs—Inflammasome Therapeutics, a private, clinical-stage biotech company developing novel, first-in-class, dual... Read more.
Owlet Partners With OpenSynergy to Power Next-Generation Bluetooth® Connectivity in Dream Sight Baby Monitor
Partnership underscores Owlet’s commitment to delivering trusted, seamless, and secure connected experiences for families worldwide. BERLIN & LEHI, Utah–(BUSINESS... Read more.
Patient Square Capital Completes Acquisition of Premier, Inc.
CHARLOTTE, N.C.–(BUSINESS WIRE)–Premier, Inc. (“Premier” or the “Company”), a leading technology-driven health care improvement company, today... Read more.